Ligand validation:4E49

RCO: RESORCINOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4E49_RCO_A_303	88%	19%	0.097	0.972	1.69	1.74	2	2	0	0	100%	1
4E49_RCO_A_305	86%	37%	0.085	0.952	1.27	1.2	1	2	0	0	100%	1
4E49_RCO_A_304	82%	5%	0.097	0.952	1.71	3.44	3	3	0	0	100%	1
4E49_RCO_A_306	61%	39%	0.153	0.942	1.46	0.92	3	-	0	0	100%	1
2OM0_RCO_U_704	99%	57%	0.051	0.987	1.15	0.53	1	-	0	0	100%	1
2OLY_RCO_C_504	98%	71%	0.061	0.984	0.83	0.32	-	-	0	0	100%	1
2OM1_RCO_G_1002	98%	65%	0.062	0.984	0.83	0.51	-	-	0	0	100%	1
4AJX_RCO_J_1029	97%	65%	0.074	0.989	0.34	0.99	-	-	0	0	100%	1
2OMI_RCO_A_301	91%	39%	0.093	0.978	1.07	1.31	1	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.